Bobak R. Azamian, President/CEO and Board Chair: Tarsus Pharmaceuticals TARS Planned sale · Filed 03/17

Trade details

Type: Planned sale notice
Stock: Tarsus Pharmaceuticals TARS
Person: Bobak R. AzamianPresident/CEO and Board Chair
Planned sale date: 26/03/17
Filed: 26/03/17

$761.6K to be sold

Tarsus Pharmaceuticals trades, last 26 weeks

What else happened in Tarsus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/15~04/16

Bobak R. Azamian's recent trades

Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$905.6K
10,000 sh
$905.6K
Filed 09/04
Traded 09/04
Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$800.6K
10,000 sh
$800.6K
Filed 09/02
Traded 09/02
Bobak R. AzamianPresident/CEO and Board Chair
Sell10b5-1 planTarsus Pharmaceuticals
Sell10b5-1 plan
Tarsus Pharmaceuticals
TARS
$334.9K
5,418 sh
$334.9K
Filed 06/22
Traded 06/17
Bobak R. AzamianPresident/CEO and Board Chair
Sell10b5-1 planTarsus Pharmaceuticals
Sell10b5-1 plan
Tarsus Pharmaceuticals
TARS
$280.6K
4,582 sh
$280.6K
Filed 06/22
Traded 06/17
Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$615.5K
10,000 sh
$615.5K
Filed 06/17
Traded 06/17

Bobak R. Azamian, Chairman — plans to sell 10,972 sh of Tarsus Pharmaceuticals TARS · $761.6K · around 03/17 | Whalegun